ACTON, Mass.--(BUSINESS WIRE)--May 16, 2019--
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless
insulin pump technology with its Omnipod® Insulin
Management System, today announced that management will present at two
upcoming investor conferences:
The 2019 UBS Global Healthcare Conference in New York City on Monday,
May 20, 2019, at 2:00 p.m. (Eastern Time).
The 2nd Annual Guggenheim MedTech Disrupters Summit in New
York City on Wednesday, May 29, 2019, at 9:10 a.m. (Eastern Time).
To listen to live audio webcasts of the presentations, please visit http://investors.insulet.com.
Replays of the webcasts will also be available following the events.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is
an innovative medical device company dedicated to making the lives of
people with diabetes and other conditions easier through the use of its
Omnipod product platform. The Omnipod Insulin Management System provides
a unique alternative to traditional insulin delivery methods. With its
simple, wearable design, the disposable Pod provides up to three days of
non-stop insulin delivery, without the need to see or handle a needle.
Insulet also leverages the unique design of its Pod by tailoring its
Omnipod technology platform for the delivery of non-insulin subcutaneous
drugs across other therapeutic areas. For more information, please
View source version on businesswire.com: https://www.businesswire.com/news/home/20190516005109/en/
Source: Insulet Corporation
Investor Relations and Media Contact:
Vice President, Investor Relations and Corporate